Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Loewen, Ondaatje, McCutcheon (LOM) is a historic Canadian investment bank and brokerage firm that has been a significant financier within the life sciences and healthcare sectors. Founded in 1970, it holds the distinction of being the first independent brokerage to gain membership on the Toronto Stock Exchange. The firm specializes in providing investment banking, institutional sales, and research services to emerging growth companies, with a strong emphasis on the biotechnology and natural resources industries. While LOM is not a therapeutic development company, it has facilitated numerous capital raises, private placements, and initial public offerings for biotech firms. Its legacy continues through various successor entities and its historical impact on the Canadian capital markets for healthcare innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Loewen Ondaatje McCutcheon.